Law

As you've probably gathered from our posts this week, the Drug and Device Law blog is going on a brief hiatus as we move to an upgraded platform.  We have well over 3000 posts, and it takes our technical people time to move them all and check all the various links.  That requires us to go dark on this coming Monday and Tuesday, but we look forward to bringing you our usual updates and analysis on drug and device product liability cases at our new site starting on Wednesday.

At that point, you'll be able to visit us at DrugAndDeviceLawBlog.com (please note this URL will not be live until May 24).  Don't worry about old bookmarks.  If you try to come to this site in the future, you'll be automatically redirected to our new home.  That means that, if you've bookmarked any particular post or guide, those links will also redirect you to that exact same post or guide on the new site.  All the redirecting should be seamless.

If you receive the Drug and Device Law posts via e-mail – and more than 1000 email addresses do – you will have to fill out a short (3 item) new e-mail subscription form here.  We're sorry for the inconvenience, but we can't legally redirect our subscriber's email addresses unilaterally, and we figure if anyone can appreciate the law, it's our readers.  After you complete the form, you'll receive an e-mail at the address you provide.  Just click on the link to confirm your subscription, and you're (and we're) in business.

Have a great weekend, everyone, and keep those defense wins coming.  We'll see you Wednesday.